CAT: Catalase Gene
Key antioxidant enzyme gene involved in hydrogen peroxide degradation and associated with acatalasemia and oxidative stress-related disorders
Gene Information Card
| Symbol | CAT |
|---|---|
| Full Name | Catalase |
| Gene Type | Protein-coding |
| Chromosomal Location | 11p13 |
| NCBI Gene ID | 847 ncbi.nlm.nih.gov/gene/847 |
| Ensembl ID | ENSG00000121691 |
| UniProt ID | P04040 |
| OMIM ID | 115500 |
| HGNC ID | 1516 |
| Aliases | CAT, MGC138422, MGC138424 |
Description
The CAT gene encodes catalase, a heme-containing enzyme that catalyzes the decomposition of hydrogen peroxide to water and oxygen, protecting cells from oxidative damage. It is located on chromosome 11p13 and is expressed in nearly all tissues, with highest levels in liver, kidney, and erythrocytes. Mutations in CAT cause acatalasemia (Takahara disease), a condition characterized by reduced catalase activity and increased susceptibility to oxidative stress.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Acatalasemia | Loss-of-function mutations in CAT reduce catalase activity, leading to accumulation of hydrogen peroxide and tissue damage, particularly in oral mucosa and erythrocytes. | OMIM #115500; multiple reports of homozygous or compound heterozygous mutations |
| Diabetes mellitus type 2 | Reduced catalase activity contributes to oxidative stress and insulin resistance; polymorphisms in CAT are associated with increased risk. | ClinVar; GWAS studies |
| Hypertension | Oxidative stress from impaired catalase function may contribute to vascular damage and elevated blood pressure. | ClinVar; case-control studies |
| Alzheimer disease | Oxidative stress and reduced catalase activity in brain tissues are implicated in neurodegeneration. | NCBI Gene; literature review |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | 123.4 | High |
| Kidney | 98.2 | High |
| Erythrocytes | 85.6 | High |
| Lung | 45.3 | Medium |
| Heart | 32.1 | Medium |
| Brain | 12.8 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 | 150.2 | Hepatocellular carcinoma cell line; high expression |
| HEK293 | 78.5 | Embryonic kidney cells; moderate expression |
| K562 | 55.3 | Chronic myelogenous leukemia; moderate expression |
| A549 | 40.1 | Lung carcinoma; moderate expression |
| MCF7 | 22.4 | Breast cancer; low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.111C>T (p.Gln37Ter) | Nonsense | <0.1% | Loss of function; associated with acatalasemia |
| c.5C>T (p.Pro2Leu) | Missense | <0.1% | Reduced enzyme activity; reported in acatalasemia |
| c.67A>G (p.Asn23Asp) | Missense | <0.1% | Decreased catalase activity; found in Japanese acatalasemia patients |
| c.127G>A (p.Glu43Lys) | Missense | <0.1% | Impaired heme binding; loss of function |
Mutation functional classification
Loss of Function (LOF)
Nonsense and missense mutations that reduce or abolish catalase activity, leading to acatalasemia and increased oxidative stress.
Gain of Function (GOF)
No gain-of-function mutations reported for CAT.
Dominant Negative (DN)
No dominant-negative mutations reported; acatalasemia is typically recessive.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Reactome: Detoxification of Reactive Oxygen Species (R-HSA-3299685)
• KEGG: Peroxisome (hsa04146)
• KEGG: Tryptophan metabolism (hsa00380)
Protein Summary
Catalase is a homotetrameric heme-containing enzyme of approximately 240 kDa. It is primarily localized in peroxisomes and mitochondria, where it catalyzes the conversion of hydrogen peroxide to water and oxygen, a critical step in cellular antioxidant defense. The protein consists of four identical subunits, each containing a heme group and NADPH binding site. Catalase is highly expressed in liver and erythrocytes, and its deficiency leads to acatalasemia, characterized by oral ulcers and gangrene. Post-translational modifications include glycosylation and phosphorylation, which modulate activity.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CAT Knockout HEK293 Cell Line | EDJ-KQ1543 | Human | 847 | Details Get a Quote |
| LPCAT3 Knockout HEK293 Cell Line | EDJ-KQ2008 | Human | 10162 | Details Get a Quote |
| ACAT1 Knockout HEK293 Cell Line | EDJ-KQ2122 | Human | 38 | Details Get a Quote |
| BCAT1 Knockout HEK293 Cell Line | EDJ-KQ3038 | Human | 586 | Details Get a Quote |
| ACAT2 Knockout HEK293 Cell Line | EDJ-KQ3994 | Human | 39 | Details Get a Quote |
| BCAT2 Knockout HEK293 Cell Line | EDJ-KQ4126 | Human | 587 | Details Get a Quote |
| CATSPER2 Knockout HEK293 Cell Line | EDJ-KQ6933 | Human | 117155 | Details Get a Quote |
| CATSPER1 Knockout HEK293 Cell Line | EDJ-KQ7593 | Human | 117144 | Details Get a Quote |
| GCAT Knockout HEK293 Cell Line | EDJ-KQ8020 | Human | 23464 | Details Get a Quote |
| CATSPERZ Knockout HEK293 Cell Line | EDJ-KQ8271 | Human | 25858 | Details Get a Quote |
| MCAT Knockout HEK293 Cell Line | EDJ-KQ8773 | Human | 27349 | Details Get a Quote |
| LPCAT4 Knockout HEK293 Cell Line | EDJ-KQ11772 | Human | 254531 | Details Get a Quote |
| CATSPERE Knockout HEK293 Cell Line | EDJ-KQ11856 | Human | 257044 | Details Get a Quote |
| CATSPERD Knockout HEK293 Cell Line | EDJ-KQ11857 | Human | 257062 | Details Get a Quote |
| BLACAT1 Knockout HEK293 Cell Line | EDJ-KQ12119 | Human | 101669762 | Details Get a Quote |
Displaying Records 1 To 15 Of 106 Records
- 1
- 2
- Next Page »